Molecular epidemiology of echovirus 30: temporal circulation and prevalence of single lineages.
Identifieur interne : 000651 ( Main/Exploration ); précédent : 000650; suivant : 000652Molecular epidemiology of echovirus 30: temporal circulation and prevalence of single lineages.
Auteurs : G. Palacios [Argentine] ; I. Casas ; D. Cisterna ; G. Trallero ; A. Tenorio ; C. FreireSource :
- Journal of virology [ 0022-538X ] ; 2002.
Descripteurs français
- KwdFr :
- Argentine (épidémiologie), Capside (génétique), Données de séquences moléculaires (MeSH), Entérovirus humain B (classification), Entérovirus humain B (génétique), Espagne (épidémiologie), Humains (MeSH), Infections à entérovirus (épidémiologie), Phylogenèse (MeSH), Protéines de capside (MeSH), Épidémiologie moléculaire (MeSH).
- MESH :
- génétique : Capside, Entérovirus humain B.
- épidémiologie : Argentine, Entérovirus humain B, Espagne, Infections à entérovirus.
- Données de séquences moléculaires, Humains, Phylogenèse, Protéines de capside, Épidémiologie moléculaire.
- Wicri :
English descriptors
- KwdEn :
- MESH :
- chemical : Capsid Proteins.
- geographic , epidemiology : Argentina, Spain.
- classification : Enterovirus B, Human.
- epidemiology : Enterovirus Infections.
- genetics : Capsid, Enterovirus B, Human.
- Humans, Molecular Epidemiology, Molecular Sequence Data, Phylogeny.
Abstract
Echovirus 30 (EV30) is one of the most frequently isolated EVs, causing extensive outbreaks of EV30 aseptic meningitis in temperate climates. EV30 is antigenically heterogeneous, and three major antigenic groups have been defined, although the basis for the antigenic differences is unknown. A reverse transcription-nested PCR which amplifies the 3'-terminal region of the VP1 gene directly from clinical samples was selected for studying EV30 molecular epidemiology, since the major antigenic sites in this region reflect the serotypic pattern of this virus. The different previous approaches to the genetic classification of EV30 were analyzed. A complete study of the EV30 strains was performed by analyzing the sequences from the 112 EV30 strains amplified in this work and the complete set of EV30 strains previously published. A total of 318 strains of EV30 were divided into two broad genotypes (I and II). This classification was supported by the phylogenetic trees obtained from amino acid sequences, and it correlated with the antigenic heterogeneity of the reference strains described in earlier studies. The genotypes could be further divided into subgroups, and these subgroups could be divided into lineages based on their nucleotide distances and levels of bootstrapping. On the other hand, the subgroups and lineages did not result in the same correlation between amino acid and nucleotide differentiation. The molecular epidemiology of EV30 can be compared to influenza virus epidemiology, where prevailing lineages displace the less established lineages on the basis of immune escape. This pattern of evolution is clearly different from that of other enteroviruses. A single lineage at a time appears to be circulating worldwide. This behavior may be related to the epidemic activity of EV30.
DOI: 10.1128/jvi.76.10.4940-4949.2002
PubMed: 11967311
PubMed Central: PMC136144
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Molecular epidemiology of echovirus 30: temporal circulation and prevalence of single lineages.</title><author><name sortKey="Palacios, G" sort="Palacios, G" uniqKey="Palacios G" first="G" last="Palacios">G. Palacios</name><affiliation wicri:level="1"><nlm:affiliation>Neurovirosis Division, Virology Department, Instituto Nacional de Enfermedades Infecciosas-ANLIS Dr. Carlos G. Malbrán, Buenos Aires, Argentina. gpalacios@impsat1.com.ar</nlm:affiliation><country xml:lang="fr">Argentine</country><wicri:regionArea>Neurovirosis Division, Virology Department, Instituto Nacional de Enfermedades Infecciosas-ANLIS Dr. Carlos G. Malbrán, Buenos Aires</wicri:regionArea><wicri:noRegion>Buenos Aires</wicri:noRegion></affiliation></author><author><name sortKey="Casas, I" sort="Casas, I" uniqKey="Casas I" first="I" last="Casas">I. Casas</name></author><author><name sortKey="Cisterna, D" sort="Cisterna, D" uniqKey="Cisterna D" first="D" last="Cisterna">D. Cisterna</name></author><author><name sortKey="Trallero, G" sort="Trallero, G" uniqKey="Trallero G" first="G" last="Trallero">G. Trallero</name></author><author><name sortKey="Tenorio, A" sort="Tenorio, A" uniqKey="Tenorio A" first="A" last="Tenorio">A. Tenorio</name></author><author><name sortKey="Freire, C" sort="Freire, C" uniqKey="Freire C" first="C" last="Freire">C. Freire</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2002">2002</date><idno type="RBID">pubmed:11967311</idno><idno type="pmid">11967311</idno><idno type="pmc">PMC136144</idno><idno type="doi">10.1128/jvi.76.10.4940-4949.2002</idno><idno type="wicri:Area/Main/Corpus">00653</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">00653</idno><idno type="wicri:Area/Main/Curation">000653</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000653</idno><idno type="wicri:Area/Main/Exploration">000653</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Molecular epidemiology of echovirus 30: temporal circulation and prevalence of single lineages.</title><author><name sortKey="Palacios, G" sort="Palacios, G" uniqKey="Palacios G" first="G" last="Palacios">G. Palacios</name><affiliation wicri:level="1"><nlm:affiliation>Neurovirosis Division, Virology Department, Instituto Nacional de Enfermedades Infecciosas-ANLIS Dr. Carlos G. Malbrán, Buenos Aires, Argentina. gpalacios@impsat1.com.ar</nlm:affiliation><country xml:lang="fr">Argentine</country><wicri:regionArea>Neurovirosis Division, Virology Department, Instituto Nacional de Enfermedades Infecciosas-ANLIS Dr. Carlos G. Malbrán, Buenos Aires</wicri:regionArea><wicri:noRegion>Buenos Aires</wicri:noRegion></affiliation></author><author><name sortKey="Casas, I" sort="Casas, I" uniqKey="Casas I" first="I" last="Casas">I. Casas</name></author><author><name sortKey="Cisterna, D" sort="Cisterna, D" uniqKey="Cisterna D" first="D" last="Cisterna">D. Cisterna</name></author><author><name sortKey="Trallero, G" sort="Trallero, G" uniqKey="Trallero G" first="G" last="Trallero">G. Trallero</name></author><author><name sortKey="Tenorio, A" sort="Tenorio, A" uniqKey="Tenorio A" first="A" last="Tenorio">A. Tenorio</name></author><author><name sortKey="Freire, C" sort="Freire, C" uniqKey="Freire C" first="C" last="Freire">C. Freire</name></author></analytic><series><title level="j">Journal of virology</title><idno type="ISSN">0022-538X</idno><imprint><date when="2002" type="published">2002</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Argentina (epidemiology)</term><term>Capsid (genetics)</term><term>Capsid Proteins (MeSH)</term><term>Enterovirus B, Human (classification)</term><term>Enterovirus B, Human (genetics)</term><term>Enterovirus Infections (epidemiology)</term><term>Humans (MeSH)</term><term>Molecular Epidemiology (MeSH)</term><term>Molecular Sequence Data (MeSH)</term><term>Phylogeny (MeSH)</term><term>Spain (epidemiology)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Argentine (épidémiologie)</term><term>Capside (génétique)</term><term>Données de séquences moléculaires (MeSH)</term><term>Entérovirus humain B (classification)</term><term>Entérovirus humain B (génétique)</term><term>Espagne (épidémiologie)</term><term>Humains (MeSH)</term><term>Infections à entérovirus (épidémiologie)</term><term>Phylogenèse (MeSH)</term><term>Protéines de capside (MeSH)</term><term>Épidémiologie moléculaire (MeSH)</term></keywords><keywords scheme="MESH" type="chemical" xml:lang="en"><term>Capsid Proteins</term></keywords><keywords scheme="MESH" type="geographic" qualifier="epidemiology" xml:lang="en"><term>Argentina</term><term>Spain</term></keywords><keywords scheme="MESH" qualifier="classification" xml:lang="en"><term>Enterovirus B, Human</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Enterovirus Infections</term></keywords><keywords scheme="MESH" qualifier="genetics" xml:lang="en"><term>Capsid</term><term>Enterovirus B, Human</term></keywords><keywords scheme="MESH" qualifier="génétique" xml:lang="fr"><term>Capside</term><term>Entérovirus humain B</term></keywords><keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Argentine</term><term>Entérovirus humain B</term><term>Espagne</term><term>Infections à entérovirus</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Humans</term><term>Molecular Epidemiology</term><term>Molecular Sequence Data</term><term>Phylogeny</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Données de séquences moléculaires</term><term>Humains</term><term>Phylogenèse</term><term>Protéines de capside</term><term>Épidémiologie moléculaire</term></keywords><keywords scheme="Wicri" type="geographic" xml:lang="fr"><term>Argentine</term><term>Espagne</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Echovirus 30 (EV30) is one of the most frequently isolated EVs, causing extensive outbreaks of EV30 aseptic meningitis in temperate climates. EV30 is antigenically heterogeneous, and three major antigenic groups have been defined, although the basis for the antigenic differences is unknown. A reverse transcription-nested PCR which amplifies the 3'-terminal region of the VP1 gene directly from clinical samples was selected for studying EV30 molecular epidemiology, since the major antigenic sites in this region reflect the serotypic pattern of this virus. The different previous approaches to the genetic classification of EV30 were analyzed. A complete study of the EV30 strains was performed by analyzing the sequences from the 112 EV30 strains amplified in this work and the complete set of EV30 strains previously published. A total of 318 strains of EV30 were divided into two broad genotypes (I and II). This classification was supported by the phylogenetic trees obtained from amino acid sequences, and it correlated with the antigenic heterogeneity of the reference strains described in earlier studies. The genotypes could be further divided into subgroups, and these subgroups could be divided into lineages based on their nucleotide distances and levels of bootstrapping. On the other hand, the subgroups and lineages did not result in the same correlation between amino acid and nucleotide differentiation. The molecular epidemiology of EV30 can be compared to influenza virus epidemiology, where prevailing lineages displace the less established lineages on the basis of immune escape. This pattern of evolution is clearly different from that of other enteroviruses. A single lineage at a time appears to be circulating worldwide. This behavior may be related to the epidemic activity of EV30.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">11967311</PMID><DateCompleted><Year>2002</Year><Month>06</Month><Day>07</Day></DateCompleted><DateRevised><Year>2019</Year><Month>05</Month><Day>08</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0022-538X</ISSN><JournalIssue CitedMedium="Print"><Volume>76</Volume><Issue>10</Issue><PubDate><Year>2002</Year><Month>May</Month></PubDate></JournalIssue><Title>Journal of virology</Title><ISOAbbreviation>J. Virol.</ISOAbbreviation></Journal><ArticleTitle>Molecular epidemiology of echovirus 30: temporal circulation and prevalence of single lineages.</ArticleTitle><Pagination><MedlinePgn>4940-9</MedlinePgn></Pagination><Abstract><AbstractText>Echovirus 30 (EV30) is one of the most frequently isolated EVs, causing extensive outbreaks of EV30 aseptic meningitis in temperate climates. EV30 is antigenically heterogeneous, and three major antigenic groups have been defined, although the basis for the antigenic differences is unknown. A reverse transcription-nested PCR which amplifies the 3'-terminal region of the VP1 gene directly from clinical samples was selected for studying EV30 molecular epidemiology, since the major antigenic sites in this region reflect the serotypic pattern of this virus. The different previous approaches to the genetic classification of EV30 were analyzed. A complete study of the EV30 strains was performed by analyzing the sequences from the 112 EV30 strains amplified in this work and the complete set of EV30 strains previously published. A total of 318 strains of EV30 were divided into two broad genotypes (I and II). This classification was supported by the phylogenetic trees obtained from amino acid sequences, and it correlated with the antigenic heterogeneity of the reference strains described in earlier studies. The genotypes could be further divided into subgroups, and these subgroups could be divided into lineages based on their nucleotide distances and levels of bootstrapping. On the other hand, the subgroups and lineages did not result in the same correlation between amino acid and nucleotide differentiation. The molecular epidemiology of EV30 can be compared to influenza virus epidemiology, where prevailing lineages displace the less established lineages on the basis of immune escape. This pattern of evolution is clearly different from that of other enteroviruses. A single lineage at a time appears to be circulating worldwide. This behavior may be related to the epidemic activity of EV30.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Palacios</LastName><ForeName>G</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Neurovirosis Division, Virology Department, Instituto Nacional de Enfermedades Infecciosas-ANLIS Dr. Carlos G. Malbrán, Buenos Aires, Argentina. gpalacios@impsat1.com.ar</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Casas</LastName><ForeName>I</ForeName><Initials>I</Initials></Author><Author ValidYN="Y"><LastName>Cisterna</LastName><ForeName>D</ForeName><Initials>D</Initials></Author><Author ValidYN="Y"><LastName>Trallero</LastName><ForeName>G</ForeName><Initials>G</Initials></Author><Author ValidYN="Y"><LastName>Tenorio</LastName><ForeName>A</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Freire</LastName><ForeName>C</ForeName><Initials>C</Initials></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>GENBANK</DataBankName><AccessionNumberList><AccessionNumber>AF391858</AccessionNumber><AccessionNumber>AF391859</AccessionNumber><AccessionNumber>AF391860</AccessionNumber><AccessionNumber>AF391861</AccessionNumber><AccessionNumber>AF391862</AccessionNumber><AccessionNumber>AF391863</AccessionNumber><AccessionNumber>AF391864</AccessionNumber><AccessionNumber>AF391865</AccessionNumber><AccessionNumber>AF391866</AccessionNumber><AccessionNumber>AF391867</AccessionNumber><AccessionNumber>AF391868</AccessionNumber><AccessionNumber>AF391869</AccessionNumber><AccessionNumber>AF391870</AccessionNumber><AccessionNumber>AF391871</AccessionNumber><AccessionNumber>AF391872</AccessionNumber><AccessionNumber>AF391873</AccessionNumber><AccessionNumber>AF391874</AccessionNumber><AccessionNumber>AF391875</AccessionNumber><AccessionNumber>AF391876</AccessionNumber><AccessionNumber>AF391877</AccessionNumber><AccessionNumber>AF391878</AccessionNumber><AccessionNumber>AF391879</AccessionNumber><AccessionNumber>AF391880</AccessionNumber><AccessionNumber>AF391881</AccessionNumber><AccessionNumber>AF391882</AccessionNumber><AccessionNumber>AF391883</AccessionNumber><AccessionNumber>AF391884</AccessionNumber><AccessionNumber>AF391885</AccessionNumber><AccessionNumber>AF391886</AccessionNumber><AccessionNumber>AF391887</AccessionNumber><AccessionNumber>AF391888</AccessionNumber><AccessionNumber>AF391889</AccessionNumber><AccessionNumber>AF391890</AccessionNumber><AccessionNumber>AF391891</AccessionNumber><AccessionNumber>AF391892</AccessionNumber><AccessionNumber>AF391893</AccessionNumber><AccessionNumber>AF391894</AccessionNumber><AccessionNumber>AF391895</AccessionNumber><AccessionNumber>AF391896</AccessionNumber><AccessionNumber>AF391897</AccessionNumber><AccessionNumber>AF391898</AccessionNumber><AccessionNumber>AF391899</AccessionNumber><AccessionNumber>AF391900</AccessionNumber><AccessionNumber>AF391901</AccessionNumber><AccessionNumber>AF391902</AccessionNumber><AccessionNumber>AF391903</AccessionNumber><AccessionNumber>AF391904</AccessionNumber><AccessionNumber>AF391905</AccessionNumber><AccessionNumber>AF391906</AccessionNumber><AccessionNumber>AF391907</AccessionNumber><AccessionNumber>AF391908</AccessionNumber><AccessionNumber>AF391909</AccessionNumber><AccessionNumber>AF391910</AccessionNumber><AccessionNumber>AF391911</AccessionNumber><AccessionNumber>AF391912</AccessionNumber><AccessionNumber>AF391913</AccessionNumber><AccessionNumber>AF391914</AccessionNumber><AccessionNumber>AF391915</AccessionNumber><AccessionNumber>AF391916</AccessionNumber><AccessionNumber>AF391917</AccessionNumber><AccessionNumber>AF391918</AccessionNumber><AccessionNumber>AF391919</AccessionNumber><AccessionNumber>AF391920</AccessionNumber><AccessionNumber>AF391921</AccessionNumber><AccessionNumber>AF391922</AccessionNumber><AccessionNumber>AF391923</AccessionNumber><AccessionNumber>AF391924</AccessionNumber><AccessionNumber>AF391925</AccessionNumber><AccessionNumber>AF391926</AccessionNumber><AccessionNumber>AF391927</AccessionNumber><AccessionNumber>AF391928</AccessionNumber><AccessionNumber>AF391929</AccessionNumber><AccessionNumber>AF391930</AccessionNumber><AccessionNumber>AF391931</AccessionNumber><AccessionNumber>AF391932</AccessionNumber><AccessionNumber>AF391933</AccessionNumber><AccessionNumber>AF391934</AccessionNumber><AccessionNumber>AF391935</AccessionNumber><AccessionNumber>AF391936</AccessionNumber><AccessionNumber>AF391937</AccessionNumber><AccessionNumber>AF391938</AccessionNumber><AccessionNumber>AF391939</AccessionNumber><AccessionNumber>AF391940</AccessionNumber><AccessionNumber>AF391941</AccessionNumber><AccessionNumber>AF391942</AccessionNumber><AccessionNumber>AF391943</AccessionNumber><AccessionNumber>AF391944</AccessionNumber><AccessionNumber>AF391945</AccessionNumber><AccessionNumber>AF391946</AccessionNumber><AccessionNumber>AF391947</AccessionNumber><AccessionNumber>AF391948</AccessionNumber><AccessionNumber>AF391949</AccessionNumber><AccessionNumber>AF391950</AccessionNumber><AccessionNumber>AF391951</AccessionNumber><AccessionNumber>AF391952</AccessionNumber><AccessionNumber>AF391953</AccessionNumber><AccessionNumber>AF391954</AccessionNumber><AccessionNumber>AF391955</AccessionNumber><AccessionNumber>AF391956</AccessionNumber><AccessionNumber>AF391957</AccessionNumber><AccessionNumber>AF391958</AccessionNumber><AccessionNumber>AF391959</AccessionNumber><AccessionNumber>AF391960</AccessionNumber><AccessionNumber>AF391961</AccessionNumber><AccessionNumber>AF391962</AccessionNumber><AccessionNumber>AF391963</AccessionNumber><AccessionNumber>AF391964</AccessionNumber><AccessionNumber>AF391965</AccessionNumber><AccessionNumber>AF391966</AccessionNumber><AccessionNumber>AF391967</AccessionNumber><AccessionNumber>AF391968</AccessionNumber><AccessionNumber>AF391969</AccessionNumber><AccessionNumber>AF391970</AccessionNumber><AccessionNumber>AF391971</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Virol</MedlineTA><NlmUniqueID>0113724</NlmUniqueID><ISSNLinking>0022-538X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D036022">Capsid Proteins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001118" MajorTopicYN="N" Type="Geographic">Argentina</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002213" MajorTopicYN="N">Capsid</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D036022" MajorTopicYN="N">Capsid Proteins</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D029822" MajorTopicYN="N">Enterovirus B, Human</DescriptorName><QualifierName UI="Q000145" MajorTopicYN="N">classification</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004769" MajorTopicYN="N">Enterovirus Infections</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017720" MajorTopicYN="N">Molecular Epidemiology</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008969" MajorTopicYN="N">Molecular Sequence Data</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010802" MajorTopicYN="N">Phylogeny</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013030" MajorTopicYN="N" Type="Geographic">Spain</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2002</Year><Month>4</Month><Day>23</Day><Hour>10</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2002</Year><Month>6</Month><Day>12</Day><Hour>10</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2002</Year><Month>4</Month><Day>23</Day><Hour>10</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">11967311</ArticleId><ArticleId IdType="pmc">PMC136144</ArticleId><ArticleId IdType="doi">10.1128/jvi.76.10.4940-4949.2002</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>J Virol. 1999 Dec;73(12):9969-75</Citation><ArticleIdList><ArticleId IdType="pubmed">10559310</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Microbiol. 1999 May;37(5):1288-93</Citation><ArticleIdList><ArticleId IdType="pubmed">10203472</ArticleId></ArticleIdList></Reference><Reference><Citation>J Gen Virol. 2000 Mar;81(Pt 3):803-12</Citation><ArticleIdList><ArticleId IdType="pubmed">10675418</ArticleId></ArticleIdList></Reference><Reference><Citation>J Gen Virol. 2000 May;81(Pt 5):1361-72</Citation><ArticleIdList><ArticleId IdType="pubmed">10769080</ArticleId></ArticleIdList></Reference><Reference><Citation>Epidemiol Infect. 2000 Jun;124(3):497-506</Citation><ArticleIdList><ArticleId IdType="pubmed">10982074</ArticleId></ArticleIdList></Reference><Reference><Citation>J Med Virol. 2001 Jan;63(1):35-44</Citation><ArticleIdList><ArticleId IdType="pubmed">11130885</ArticleId></ArticleIdList></Reference><Reference><Citation>J Gen Virol. 2001 Jan;82(Pt 1):79-91</Citation><ArticleIdList><ArticleId IdType="pubmed">11125161</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Virol. 2001;146(3):521-37</Citation><ArticleIdList><ArticleId IdType="pubmed">11338388</ArticleId></ArticleIdList></Reference><Reference><Citation>J Med Virol. 2001 Sep;65(1):138-48</Citation><ArticleIdList><ArticleId IdType="pubmed">11505456</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Epidemiol. 1967 Mar;85(2):240-9</Citation><ArticleIdList><ArticleId IdType="pubmed">6020795</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Gesamte Virusforsch. 1968;25(1):93-104</Citation><ArticleIdList><ArticleId IdType="pubmed">4977766</ArticleId></ArticleIdList></Reference><Reference><Citation>Virology. 1987 Oct;160(2):311-22</Citation><ArticleIdList><ArticleId IdType="pubmed">2821678</ArticleId></ArticleIdList></Reference><Reference><Citation>J Pediatr. 1988 Dec;113(6):975-8</Citation><ArticleIdList><ArticleId IdType="pubmed">2848117</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol Methods. 1995 May;53(1):25-36</Citation><ArticleIdList><ArticleId IdType="pubmed">7635925</ArticleId></ArticleIdList></Reference><Reference><Citation>Virus Res. 1998 Nov;58(1-2):35-43</Citation><ArticleIdList><ArticleId IdType="pubmed">9879760</ArticleId></ArticleIdList></Reference><Reference><Citation>J Gen Virol. 1999 Mar;80 ( Pt 3):639-51</Citation><ArticleIdList><ArticleId IdType="pubmed">10092004</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Microbiol. 1999 Dec;37(12):3928-33</Citation><ArticleIdList><ArticleId IdType="pubmed">10565909</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></pubmed><affiliations><list><country><li>Argentine</li></country></list><tree><noCountry><name sortKey="Casas, I" sort="Casas, I" uniqKey="Casas I" first="I" last="Casas">I. Casas</name><name sortKey="Cisterna, D" sort="Cisterna, D" uniqKey="Cisterna D" first="D" last="Cisterna">D. Cisterna</name><name sortKey="Freire, C" sort="Freire, C" uniqKey="Freire C" first="C" last="Freire">C. Freire</name><name sortKey="Tenorio, A" sort="Tenorio, A" uniqKey="Tenorio A" first="A" last="Tenorio">A. Tenorio</name><name sortKey="Trallero, G" sort="Trallero, G" uniqKey="Trallero G" first="G" last="Trallero">G. Trallero</name></noCountry><country name="Argentine"><noRegion><name sortKey="Palacios, G" sort="Palacios, G" uniqKey="Palacios G" first="G" last="Palacios">G. Palacios</name></noRegion></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/GrippeEspagneV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000651 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000651 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= GrippeEspagneV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:11967311
|texte= Molecular epidemiology of echovirus 30: temporal circulation and prevalence of single lineages.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:11967311" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a GrippeEspagneV1
| This area was generated with Dilib version V0.6.37. |  |